Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

- Corry, June, Moore, Alisha, Mcdowell, Lachlan, Wilkinson, Dean, Tiong, Albert, Rischin, Danny, Kenny, Liz, Wratten, Chris, Fua, Tsien, Lin, Charles, Porceddu, Sandro, Liu, Chen, Ruemelin, Michael, Sharkey, Amy

Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison

- Taylor, Paige A., Miles, Elizabeth, Corning, Coreen, Effeney, Rachel, Healy, Brendan, Moore, Alisha, Nakamura, Mitsuhiro, Patel, Samir, Shaw, Maddison, Stock, Markus, Lehmann, Joerg, Clark, Catharine H., Hoffmann, Lone, Kelly, Sarah M., Kry, Stephen F., Møller, Ditte Sloth, Palmans, Hugo, Akbarov, Kamal, Aznar, Marianne C., Clementel, Enrico

SEAFARER – A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice: SEAFARER - sensitivity of patient specific quality assurance, PSQA

- Lehmann, Joerg, Hussein, Mohammad, Claridge Mackonis, Elizabeth, Meehan, Carole, Patel, Rushil, Ray, Xenia, Shaw, Maddison, Shepherd, Justin, Smyth, Gregory, Standen, Therese S., Subramanian, Brindha, Greer, Peter B., Barry, Miriam A., Clark, Catharine H., Siva, Shankar, Moore, Alisha, Chu, Michael, Díez, Patricia, Eaton, David J., Harwood, Jeffrey, Lonski, Peta

Can radiation therapy quality assurance improve nasopharyngeal cancer outcomes in low- and middle-income countries: reporting the first phase of a prospective international atomic energy agency study

- Corry, June, Ng, Wai Tong, Moore, Alisha, Choi, Horace C. W., Le, Quynh, Holmes, Sofee, Munandar, Arie, Wang, Shengzi, Camacho, Angela, Setakornnukul, Jiraporn, Jiarpinitnun, Chuleeporn, Hiep, P. N., Laskar, Sarbani Ghosh, Benjaafar, Noureddine, Faheem, Mohammad, Jin, Feng, Ben Ammar, Chiraz Nasr, Ali, Rubina, Boualga, Kada, Abdelwahab, Sherif, Sommat, Kiattisa, Tao, Y, O'Sullivan, B, Lee, N, Zubizaretta, E, Prajogi, B, Hopkins, K, Rosenblatt, E, Lee, AWM

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines: GHG OAR consensus contouring guidance

- Mir, Romaana, Kelly, Sarah M., Ishikura, Satoshi, Kristensen, Ingrid, Kry, Stephen F., Lehmann, Joerg, Michalski, Jeff M., Monti, Angelo F., Nakamura, Mitsuhiro, Thompson, Kenton, Yang, Huiqi, Zubizarreta, Eduardo, Xiao, Ying, Andratschke, N, Miles, E, Moore, Alisha, Clark, Catharine H., Clementel, Enrico, Corning, Coreen, Ebert, Martin, Hoskin, Peter, Hurkmans, Coen W.

A remote EPID-based dosimetric TPS-planned audit of centers for clinical trials: outcomes and analysis of contributing factors

- Miri, Narges, Legge, Kimberley, Colyvas, Kim, Lehmann, Joerg, Vial, Philip, Moore, Alisha, Harris, Monica, Greer, Peter B.